WDR5 Represents a Therapeutically Exploitable Target for Cancer Stem Cells in Glioblastoma

In glioblastomas CSCs, WDR5 inhibitors blocked WRAD complex assembly and reduced H3K4 trimethylation and expression of genes involved in CSC-relevant oncogenic pathways.